Transcutaneous Vagus Nerve Stimulation (tVNS) as a Complementary Treatment Method
The vagus nerve is a cranial nerve that belongs to the parasympathetic division of the autonomic nervous system. It regulates the activity of numerous internal organs, and vagal tone—indicating how effectively the nerve performs its regulatory function—is widely recognized as a physiological biomarker for stress resilience. Dysregulation of vagal tone is observed not only in somatic conditions; mental health disorders are also frequently accompanied by autonomic imbalances (such as in burnout or depression). The vital role of the autonomic nervous system in the development of both somatic and psychological or behavioral symptoms is particularly recognized within contemporary neuroscientific perspectives on psychotraumatology (see The Polyvagal Theory by Stephen Porges).
What Is Vagus Nerve Stimulation?
Surgically implanted vagus nerve stimulation (VNS) is an established clinical intervention recognized in the treatment of therapy-resistant depression.
In this procedure, an electrode and a pulse generator are implanted in the body to deliver rhythmic electrical impulses to the vagus nerve. This stimulation transmits afferent signals to limbic structures in the brain, which play a central role in emotion regulation. Originally developed for the treatment of epilepsy, clinicians soon observed a positive mood-enhancing secondary effect—an outcome repeatedly confirmed across numerous clinical studies.
A non-invasive, non-surgical alternative—and the method I apply in my practice—is transcutaneous vagus nerve stimulation (tVNS). Approved in the European Union since 2010, tVNS delivers gentle electrical impulses through the skin, stimulating either the auricular branch of the left vagus nerve along the left outer ear or, with newer devices, the cervical branch via placement on the neck.
tVNS exerts a gentle mood-elevating effect, and users consistently report a profound sense of deep relaxation induced by a tVNS session.
I integrate this method as a complementary component within my psychological treatment offerings—for example, alongside a neurofeedback treatment plan for depression, chronic pain, or burnout, as well as in conjunction with psychological counseling. Patients can rent a device to perform repeated tVNS sessions conveniently at home.
tVNS is contraindicated in cases of: pregnancy, active electronic implants (such as cardiac pacemakers or cochlear implants), and cerebral shunts.
Illustration: The human autonomic nervous system. The diagram depicts selected target organs along with the antagonistic actions of the sympathetic and parasympathetic divisions (click to enlarge). Source: Wikipedia, Autonomic Nervous System
Fiedler, U. & Bajbouj, M. (2007). Neuromodulation durch Vagusnervstimulation bei Depression. Journal für Neurologie, Neurochirurgie und Psychiatrie 8(4), 22-28. Link (10/01/2018).
Müller, T. (2011). Vagusnerv-Stimulation hilft gegen Depression. Link (10/01/2018).
Nahas, Z. et al. (2005). Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. The Journal of Clinical Psychiatry 66(9), 1097-1104.
Porges, S.W. (1995). Orienting in a defensive world: Mammalian modifications of our evolutionary heritage. A Polyvagal Theory. Psychophysiology, 32, 301-318.
Porges, S.W. (1997). Emotion: An evolutionary by-product of the neural regulation of the autonomic nervous system. In C. S. Carter, B. Kirkpatrick, & I.I. Lederhendler (eds.), The Integrative Neurobiology of Affiliation, Annals of the New York Academy of Sciences, 807, 62-77.
Porges, S.W. (1998). Love: An emergent property of the mammalian autonomic nervous system. Psychoneuroendocrinology, 23, 837-861.
Porges, S.W. (2001). The Polyvagal Theory: Phylogenetic substrates of a social nervous system. International Journal of Psychophysiology, 42, 123-146.
Rush, A.J. et al. (2005). Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial.
Sackeim, H.A. et al. (2001). Vagus Nerve Stimulation (VNS(TM)) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome. Neuropsychopharmacology 25, 713-728. Link(10/01/2018).
Shiozawa, Pedro, Silva, Mailu Enokibara da, Carvalho, Thais Cristina de, Cordeiro, Quirino, Brunoni, André R., & Fregni, Felipe. (2014). Transcutaneous vagus and trigeminal nerve stimulation for neuropsychiatric disorders: a systematic review. Arquivos de Neuro-Psiquiatria, 72(7), 542-547. Link